quipazine has been researched along with Developmental Psychomotor Disorders in 1 studies
Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganzer, PD | 1 |
| Moxon, KA | 1 |
| Knudsen, EB | 1 |
| Shumsky, JS | 1 |
1 other study available for quipazine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Serotonergic pharmacotherapy promotes cortical reorganization after spinal cord injury.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Brain Mapping; Cerebral Corte | 2013 |